Description: Adcock Ingram Holdings Limited manufactures, markets, and distributes healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It offers a portfolio of over-the-counter products, prescription medicines, and consumer products, as well as instrumentation and surgical products. The company also provides a range of pharmaceutical products, such as women's health, cannabidiol oil, antiretroviral, dermatology, central nervous system, respiratory, ophthalmology, generics, cardiovascular, pain, gastroenterology, energy supplements, colds and flu, personal care, feminine hygiene, digestive well-being, allergies, baby care, cough, food and nutrition supplements, vitamins, and minerals supplements. In addition, it manufactures and supplies hospital and critical care products, including intravenous solutions, renal dialysis systems, and blood collection products. The company serves private and public sectors. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.
Home Page: www.adcock.co.za
1 New Road
Midrand,
1682
South Africa
Phone:
27 11 635 0000
Officers
Name | Title |
---|---|
Mr. Andrew Gideon Hall CA (SA), BPharm | CEO & Exec. Director |
Ms. Dorette Neethling | CFO & Exec. Director |
Ms. Basadifeela Letsoalo | Exec. Director of Transformation & Human Capital and Exec. Director |
R. Essa | Corp. Fin. Director |
Mr. Mahlatse Phalafala | Company Sec. & Head of Legal |
Mr. Nkosinathi Mthethwa | Public Affairs Exec. |
Mr. Ashley Pearce Dip. Pharm, BCom | Managing Director of Prescription |
Mr. Colin Sheen MBA, NDip Mktg, PDBA, BTech | Managing Director of Hospital |
Mr. Tobie Krige | Managing Director of Distribution |
Mr. Azhar Kaka | Head of Sales - Consumer Division |
Exchange: JSE
Country: ZA
Currency: South African Rand cents (R)
Forward PE: | 0 |
---|---|
Trailing PE: | 10.5432 |
Price-to-Book MRQ: | 1.567 |
Price-to-Sales TTM: | 0.9474 |
IPO Date: | |
Fiscal Year End: | June |
Full Time Employees: | 0 |